Press release
United States Peptide Synthesis Market 2025 | Growth Drivers, Key Players & Investment Opportunities
Market Size and GrowthThe Global Peptide Synthesis market reached US$ 780.00 million in 2023, with a rise to US$ 860.99 million in 2024, and is expected to reach US$ 2,268.16 million by 2033, growing at a CAGR of 11.4% during the forecast period 2025-2033.
Key Development:
United States: Recent Industry Developments
✅ In October 2025, Cambrex announced a US $120 million investment to expand its API and peptide-manufacturing capacity at its Charles City, Iowa facility. The project will accelerate production of complex peptide therapeutics and strengthen the U.S. drug-supply chain.
✅ In October 2025, SK Pharmteco committed US $6.1 million to expand its Rancho Cordova, California site. The upgrade adds new laboratories and CGMP-kilo-scale solid-phase peptide synthesis and purification capabilities for advanced peptide APIs.
✅ In April 2025, Granules India Ltd completed the acquisition of 100 % equity in Senn Chemicals AG (Switzerland-based CDMO specialising in peptides) for CHF 20 million (~₹192.5 crore). The deal gives Granules a foothold in both liquid-phase and solid-phase peptide synthesis and access to regulated-market clients and peptide API pipeline.
Japan: Recent Industry Developments
✅ In 2025, Japan's peptide synthesis sector recorded strong CDMO and biotech activity, positioning it among the fastest-growing peptide hubs in Asia-Pacific. Growth is driven by rising R&D collaborations and domestic therapeutic peptide innovation.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/peptide-synthesis-market?sb
Peptide synthesis is the chemical or biological process of creating short chains of amino acids (peptides) that mimic natural proteins. It is widely used in drug development, diagnostics, and biomedical research for designing therapeutic molecules and vaccines.
Key Players:
=> Bachem, Thermo Fisher Scientific Inc., Merck, GenScript, PolyPeptide Group, Almac Group, Kaneka Eurogentec S.A., Biosynth, BCNPeptides, CPC Scientific Inc., among others.
=> Market Dynamics
Market Drivers:
✅ Growing pipeline of peptide therapeutics driving R&D investments.
✅ Rapid advances in synthesis technology and automation improving process efficiency and scalability.
Market Restraints:
✅ High cost of manufacture and purification posing challenges for large-scale production.
✅ Supply-chain and raw material risks impacting consistent product availability.
Growth Forecast Projected:
The Global Peptide Synthesis Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2033. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
Research Process:
Both primary and secondary data sources have been used in the global Peptide Synthesis Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=peptide-synthesis-market
Key Segments:
➥ By Technique: Solid Phase Synthesis, Solution Phase Synthesis, Hybrid Approach
➥ By Product Type: Equipment, Reagents & Consumables, Services
➥ By Application: Therapeutic, Diagnostics, Research
➥ By End-User: Pharmaceutical and Biotechnology Companies, CDMOs & CROs, Academic and Research Institutes, Others
Regional Analysis for Peptide Synthesis Market:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Benefits of the Report:
Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.
Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.
Chapter 3: Offers an in-depth look at the competitive landscape among Peptide Synthesis producers, including revenue shares, strategic moves, and recent mergers and acquisitions.
Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.
Chapters 5 & 6: Analyze Peptide Synthesis revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.
Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.
Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.
Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.
Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.
Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/peptide-synthesis-market?sb
FAQ
What is the current size of the Peptide Synthesis Market?
A: In 2024, the Peptide Synthesis Market was valued at US$ 860.99 million , reflecting its strong industry presence.
Q2: How large is the Peptide Synthesis Market expected to be by 2033?
A: By 2033, industry forecasts suggest the Peptide Synthesis Market will grow to around US$ 2,268.16 million , demonstrating significant expansion.
Q3: What is the growth rate of the Peptide Synthesis Market?
A: The market is projected to expand at a compound annual growth rate (CAGR) of 11.4% during the forecast period from 2025 to 2033.
Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?sb
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring
Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?sb
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release United States Peptide Synthesis Market 2025 | Growth Drivers, Key Players & Investment Opportunities here
News-ID: 4244769 • Views: …
More Releases from DataM intelligence 4 Market Research LLP
United States Drug Discovery Services Market to Reach USD 12.78 Billion by 2033 …
Drug Discovery Services Market Overview
The global drug discovery services market reached US$ 8.37 Billion in 2024, up from US$ 8.01 Billion in 2023, and is projected to reach US$ 12.78 Billion by 2033, expanding at a CAGR of 4.9% during 2025-2033. The market's growth is primarily driven by the increasing prevalence of chronic diseases, rising pharmaceutical R&D expenditure, and advancements in drug discovery technologies. Pharmaceutical companies are increasingly outsourcing their…
United States Biomaterials Market to Reach US$ 486.83 Million by 2033 | Rising A …
Leander, Texas and TOKYO, Japan - Dec.10.2025
Market Size
As per DataM Intelligence research report, "The Global Biomaterials Market reached US$ 177.30 million in 2024 and is expected to reach US$ 486.83 million by 2033, growing at a CAGR of 10.7% during the forecast period 2025-2033." Increasing applications in medical implants, tissue engineering, and drug delivery systems are driving market growth.
Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/biomaterials-market?praveen
United…
United States Blood Cancer Drugs Market to Reach USD 113.5 Billion by 2031 | Str …
Blood Cancer Drugs Market Overview
The Global Blood Cancer Drugs Market reached USD 63 billion in 2022 and is projected to grow significantly to USD 113.5 billion by 2031, exhibiting a CAGR of 7.8% during 2024-2031. The market growth is primarily driven by the rising prevalence of blood cancers, continuous advancements in cancer research, and the development of targeted therapies, immunotherapies, and personalized medicine. Increasing awareness among patients and healthcare providers,…
United States Primary Sclerosing Cholangitis Market 2031 | Growth Drivers, Key P …
Market Size and Growth
The global critical infrastructure protection market is growing at a high CAGR during the forecast period (2024-2031).
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/primary-sclerosing-cholangitis-market?sb
Key Development:
United States
✅ In December 2025, Chemomab Therapeutics published peer‐reviewed Phase 2 trial results for Nebokitug showing that 48‐week treatment in PSC patients was generally safe, well tolerated and produced sustained improvements in biomarkers linked to…
More Releases for Peptide
ShiLai Peptide to Invest $32 Million in State-of-the-Art Peptide Laboratory in H …
ShiLai Peptide's CEO, Luo Binhua, said the investment reflects the company's commitment to a "new science model" that integrates research-driven development, controlled production, and specialized customer support.
ShiLai Peptide [https://retatrutidesupplier.com/], a leading provider of high-purity, customizable research peptides, announced plans to invest $32 million to build a state-of-the-art peptide research and production laboratory in Hangzhou. The facility is designed to meet world-class GMP standards, aiming to strengthen ShiLai's global supply of…
Copper Peptide GHK-Cu Market: Empowering Beauty and Health Innovations with Adva …
The global copper peptide GHK-Cu market is poised for transformative growth as innovative cosmetic and pharmaceutical formulations increasingly incorporate these bioactive peptides to promote skin rejuvenation, wound healing, and overall wellness. Driven by technological advancements, growing consumer awareness of anti-aging solutions, and an expanding portfolio of product applications, the market is set to evolve rapidly in the coming years. This industry provides an in-depth analysis of market information, key growth…
Shaping the Cell Penetrating Peptide Market in 2025: Innovative Peptide Drug Dis …
How Big Is the Cell Penetrating Peptide Market Expected to Be, and What Will Its Growth Rate Be?
In recent times, the market size for cell penetrating peptides has expanded swiftly. The market is projected to rise from a value of $1.87 billion in 2024 to $2.16 billion in 2025, growing at a compound annual growth rate (CAGR) of 15.6%. The historic period's growth can be credited to an amplified comprehension…
Cancer Peptide Drugs Market
Global Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030 Report Highlights:
• Global Peptide Cancer Drug Market Insight By Region & Indication
• Global Peptide Cancer Drug Market Opportunity: > US$ 18 Billion
• Approved Peptide Cancer Drugs: > 30 Drugs
• Approved Peptide Cancer Drugs Sales Insights, Patent, Dosage and Price Analysis
• Peptide Cancer Drugs Clinical Trials Insight By Company, Country, Indication and Phase
• Insight On Peptide Cancer Drugs In Clinical Trials: >…
Global Adjuvant Peptide Market Size,Share, Research and Forecast,2023-2028| Pept …
The global Adjuvant Peptide market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Adjuvant Peptide market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global…
Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established…
